Don’t miss this opportunity to look at the operational and functional challenges sponsors face when designing and conducting clinical trials on children.
Featuring three case studies of EMA-approved Paediatric Investigation Plans (PIPs), key industry and academic experts, we will address the unique concerns raised by ethics committees, investigators, and parents surrounding the conduct of pediatric clinical trials. Learn how to incorporate a pediatric clinical program into you existing global clinical trials paradigm.
Register today to reserve your place at ExL’s 4th Pediatric Clinical Trials Conference – November 11-12, 2010 – Westin Washington
Join our renown speaking faculty including:
Chair: Julie A. Rosenberg, MD, Director, Oncology Global Clinical Research, BRISTOL-MYERS SQUIBB
- Charles A. Thompson, Medical Director, Infectious Diseases, PFIZER
- Gilles Vassal, MD, PhD, Director Clinical and Translational Research, INSTITUT GUSTAVE-ROUSSY, VILLEJUIF, FRANCE, EMA PDCO Member
- Kevin Connolly, FRCPI, Director, Paediatric Clinical Development, PORTIUNCULA HOSPITAL, GALWAY IRELAND, EMA PDCO Member
- Liz Morgan, EU Regulatory Affairs, Pfizer UK
- Robert “Skip” Nelson, MD, PhD, Pediatric Ethicist, Office of Pediatric Therapeutics, FOOD AND DRUG ADMINISTRATION
- Samuel C Blackman, MD, PhD, Associate Director, Experimental Medicine/Oncology, MERCK RESEARCH LABORATORIES
- Ronald Portman, MD, Chair, Pediatric Drug Development Committee, Group Director, Cardiovascular/Metabolics, BRISTOL MYERS SQUIBB
- Kenneth Cohen, MD, MBA, Clinical Director, Pediatric Oncology, Associate Professor, Oncology and Pediatrics, THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
- Ann Kottcamp, Vice President, CNS & Mental Health, MMG
- Jeffrey Skolnik, MD, Director, Clinical Research, ASTRAZENECA
- Paul Wang, MD, FAAP, Vice President, Clinical Development, SEASIDE THERAPEUTICS
- Mark De Roche, Senior Director, Regulatory Affairs, VERTEX PHARMACEUTICALS
- Emma Du Four, Director Regulatory Policy & Intelligence, Global Pharmaceutical Regulatory and Medical Sciences, ABBOTT LABORATORIES, UK
- Brahm Goldstein, MD, Senior Medical Director, Translational Science, IKARIA
- Thomas Hassall, Senior Director, Regulatory Policy & Intelligence,
- ABBOTT LABORATORIES
|
